$14.17
0.00% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US7493971052
Symbol
RCM

R1 RCM Inc Stock price

$14.17
+0.11 0.78% 1M
+1.17 9.00% 6M
+3.60 34.06% YTD
-0.90 5.97% 1Y
-7.48 34.55% 3Y
+5.06 55.54% 5Y
+6.37 81.67% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.00 0.00%
ISIN
US7493971052
Symbol
RCM
Sector

Key metrics

Market capitalization $5.98b
Enterprise Value $8.19b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 40.35
EV/Sales (TTM) EV/Sales 3.44
P/S ratio (TTM) P/S ratio 2.51
P/B ratio (TTM) P/B ratio 2.12
Revenue growth (TTM) Revenue growth 11.43%
Revenue (TTM) Revenue $2.38b
EBIT (operating result TTM) EBIT $270.70m
Free Cash Flow (TTM) Free Cash Flow $202.90m
Cash position $163.00m
EPS (TTM) EPS $-0.10
P/E forward negative
P/S forward 2.34
EV/Sales forward 3.20
Short interest 9.93%
Show more

Is R1 RCM Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

R1 RCM Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a R1 RCM Inc forecast:

1x Buy
8%
11x Hold
92%

Analyst Opinions

12 Analysts have issued a R1 RCM Inc forecast:

Buy
8%
Hold
92%

Financial data from R1 RCM Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,380 2,380
11% 11%
100%
- Direct Costs 1,897 1,897
10% 10%
80%
483 483
17% 17%
20%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
572 572
24% 24%
24%
- Depreciation and Amortization 302 302
9% 9%
13%
EBIT (Operating Income) EBIT 271 271
46% 46%
11%
Net Profit -40 -40
39% 39%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about R1 RCM Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

R1 RCM Inc Stock News

Neutral
Business Wire
20 days ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of R1 RCM Inc. (NASDAQ: RCM) to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice for $14.30 per share is fair to R1 shareholders. Halper Sadeh encourages R1 shareholders to click here to learn more about their legal rights and options or contact Da...
Neutral
Accesswire
about one month ago
PHILADELPHIA, PA / ACCESSWIRE / August 19, 2024 / Kehoe Law Firm, P.C. is investigating whether the sale of R1 RCM Inc. (NASDAQ:RCM) is fair to R1 RCM shareholders and whether the Board of Directors of R1 RCM breached its fiduciary duties in connection with the proposed acquisition of the company by investment funds affiliated with TowerBrook Capital Partners L.P.
Neutral
GlobeNewsWire
about 2 months ago
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
More R1 RCM Inc News

Company Profile

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL.

Head office United States
CEO Lee Rivas
Employees 30,000
Founded 2003
Website www.r1rcm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today